Antidepressant Use during Pregnancy and the Rates of Spontaneous Abortions: A Meta-Analysis

Abstract

Spanish

French

BACKGROUND:

Due to the high prevalence of depression in women of childbearing age and coupled with the fact that approximately 50% of the pregnancies are unplanned, there is a high chance that these women have been exposed to antidepressants in early pregnancy.

OBJECTIVE:

To determine baseline rates of spontaneous abortions (SAs) and whether antidepressants increase those rates.

METHODS:

Rates of SAs in women taking antidepressants compared with non-depressed women were combined into a relative risk using a random effects model. MEDLINE, EMBASE, Healthstar, Toxline, Psychlit, Cochrane database, and Reprotox were searched for studies published in any language from 1966 to 2003. Key words used to identify articles included pregnancy outcome, abortion, miscarriage, spontaneous, antidepressant, depression, and the generic names of each antidepressant and class. Bibliographies, review articles, and reference lists from studies were also used to identify potential articles expected to provide evidence of safety of antidepressants in pregnancy.

RESULTS:

Of 15 potential articles, 6 cohort studies of 3567 women (1534 exposed, 2033 nonexposed) provided extractable data. All matched on important confounders. Tests found no heterogeneity (χ² 3.13; p = 0.98), and all quality scores were adequate (>50%). The baseline SA rate (95% CI) was 8.7% (7.5% to 9.9%; n = 2033). For antidepressants, the rate was 12.4% (10.8% to 14.1%; n = 1534), significantly increased by 3.9% (1.9% to 6.0%); RR was 1.45 (1.19 to 1.77; n = 3567). No differences were found among antidepressant classes.

CONCLUSIONS:

Maternal exposure to antidepressants may be associated with increased risk for SA; however, depression itself cannot be ruled out.

Keywords

antidepressants depression spontaneous abortion

Get full access to this article

View all access options for this article.

References

O'Hara

. Social support, life events, and depression during pregnancy and the puerperium. Arch Gen Psychiatry 1986; 43: 569–73.

Kitamura

Shima

Sugawara

Ioda

. Psychological and social correlates of the onset of affective disorders among pregnant women. Psychosom Med 1993; 23: 967–75.

Marcus

Flynn

Blow

Barry

. Depressive symptoms among pregnant women screened in obstetric settings. J Women Health 2003; 12: 373–80.

Jarrahi-Zadeh

Kane

FJJ

Van de Castle

Lachenbruch

Ewing

. Emotional and cognitive changes in pregnancy and early puerperium. Br J Psychiatry 1969; 115: 797–805.

Goldenberg

Gotlieb

. Social and psychological factors and pregnancy outcome. In: Complications of pregnancy: Medical, surgical, gynaecologic, psychosocial and perinatal. Philadelphia: Williams and Wilkins, 1991: 80–95.

Zax

Sameroff

Babigian

. Birth outcomes in the offspring of mentally disordered women. Am J Orthopsychiatry 1977; 47: 218–9.

Zuckerman

Amaro

Bauchner

Cabral

. Depressive symptoms during pregnancy: Relationship to poor health behaviors. Am J Obstet Gynecol 1989; 160: 1107–11.

Orr

Miller

. Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings. Epidemiol Rev 1995; 17: 165–71.

Steer

Scholl

Hediger

Fischer

. Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol 1992; 45: 1093–9.

10.

Zuckerman

Bauchner

Parker

. Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Behav Pediatr 1990; 11: 190–4.

11.

Thorngren-Jerneck

Herbst

. Low 5-minute Apgar score: A population-based register study of 1 million term births. Obstet Gynecol 2001; 98: 1–7.

12.

McGrath

Sullivan

. Birth weight, neonatal morbidities, and school age outcomes in full-term and preterm infants. Issues Comprehens Pediatr Nurs 2002; 25: 231–54.

13.

Allen

. Preterm outcomes research: A critical component of neonatal intensive care. Ment Retard Dev D R 2003; 8: 221–33.

14.

Glover

. Maternal stress or anxiety in pregnancy and emotional development of the child. Br J Psychiatry 1997; 171: 105–6.

15.

Teixeira

Fisk

Glover

. Association between maternal anxiety in pregnancy and increased uterine artery resistance index: Cohort based study. BMJ 1999; 318: 153–7.

16.

Uno

Lohmiller

Thieme

. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. 1. Hippocampus. Brain Res Develop Brain Res 1990; 53: 157–67.

17.

Uno

Eisele

Sakai

. Neurotoxicity of glucocorticoids in the primate brain. Horm Behav 1994; 28: 336–48.

18.

Gotlib

Whiffen

Mount

. Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol 1989; 57: 269–74.

19.

Klein

Essex

. Pregnant or depressed? The effect of overlap between symptoms of depression and somatic complaints of pregnancy on rates of major depression in the second trimester. Depression 1994; 2: 1994–5.

20.

Pastuszak

Schick-Boschetto

Zuber

Feldkamp

Pinelli

Sihn

. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993; 269: 2246–8.

21.

Einarson

Bonari

Voyer-Lavigne

Addis

Matsui

Johnston

. A multicentre prospective controlled study to determine the safety of trazodone/nefazodone use during pregnancy. Can J Psychiatry 2003; 48: 106–10.

22.

Einarson

Fatoye

Sarkar

Lavigne

Brochu

Chambers

. Pregnancy outcome following gestational exposure to venlafaxine: A multicenter prospective controlled study. Am J Psychiatry 2001; 158: 1728–30.

23.

Kulin

Pastuszak

Sage

Schick-Boschetto

Spivey

Feldkamp

. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: A prospective controlled multicenter study. JAMA 1998; 279: 609–10.

24.

Garciá-Enguídanos

Valero

Luna

Domínguez-Rojas

. Risk factors in miscarriage: A review. Eur J Obstet Gyn R B 2002; 102: 111–9.

25.

Kesmodel

Wisborg

Olson

Henriksen

Secher

. Moderate alcohol intake in pregnancy and the risk of spontaneous abortion. Alcohol Alcoholism 2002; 37: 87–92.

26.

Regan

Braude

Trembath

. Influence of past reproductive performance on risk of spontaneous abortion. BMJ 1989; 26: 541–5.

27.

Cnattingius

Signorello

Anneren

Clausson

Ekborn

Ljunger

. Caffeine intake and the risk of first-trimester spontaneous abortions. N Engl J Med 2000; 343: 1839–45.

28.

Anatomic Therapeutic Chemical classification of drugs. Oslo: World Health Organization Collaborating Center for Drug Utilization, 2004.

29.

Cochran

. The combination of estimates from different experiments. Biometrics 1954; 10: 101–29.

30.

Bjerre

LeLorier

. Expressing the magnitude of adverse effects in case control studies: The number of patients needed to be treated for one additional patient to be harmed. BMJ 2000; 320: 503–6.

31.

Egger

Smith

Schneider

Mindcer

. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–34.

32.

Sterne

JAC

Egger

Davey

. Investigating and dealing with publication and other biases in meta-analysis. BMJ 2001; 323: 101–8.

33.

Sterne

JAC

Egger

. Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. J Clin Epidemiol 2001; 54: 1046–55.

34.

Duval

Tweedie

. Trim and fill: A simple funnel-plot—based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455–63.

35.

Sutton

Song

Gilbody

Abrams

. Modelling publication bias in meta-analysis: A review. Stat Methods Med Res 2000; 9: 421–45.

36.

Begg

Mazumdar

. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088–101.

37.

Elwood

. Critical appraisal of a cohort study. In: Causal relationships in medicine. 1st ed. Oxford: Oxford University Press, 1988: 184–210.

38.

Lichtenstein

Mulrow

Elwood

. Guidelines for reading case—control studies. J Chronic Dis 1987; 40: 893–903.

39.

Feinstein

. Observer variability. In: Clinical epidemiology. The architecture of clinical research. Philadelphia: WB Saunders, 1985: 632–48.

40.

Fleiss

. Measuring nominal scale agreement among many raters. Psychol Bull 1971; 76: 378–82.

41.

Fleiss

Nee

Landis

. The large sample variance of kappa in the case of different sets of raters. Psychol Bull 1979; 86: 974–7.

42.

Nulman

Rovet

Stewart

Wolpin

Gardner

Theis

JGW

. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997; 336: 258–62.

43.

Goldstein

Corbin

Sundell

. Effects of first-trimester fluoxetine exposure on the newborn. Obstet Gynecol 1997; 89: 713–8.

44.

Goldstein

Sundell

Corbin

. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1997; 336: 872–3.

45.

Shakir

. Data. Southampton, UK: Drug Safety Research Unit, 1999.

46.

Brunel

Vial

Roche

Bertolotti

Evreux

. Follow-up of 151 pregnant women exposed to antidepressant treatment (MAOI excluded) during organogenesis. Therapie 1994; 49: 117–22.

47.

Ericson

Kallén

Wiholm

. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol 1999; 55: 503–8.

48.

Emslie

Judge

. Tricyclic antidepressants and selective serotonin reuptake inhibitors: Use during pregnancy, in children/adolescents and in the elderly. Acta Psychiatr Scand Suppl 2000; 403: 26–34.

49.

Goldstein

. Effects of third trimester fluoxetine exposure on the newborn. J Clin Psychopharmacol 1995; 15: 417–20.

50.

Webster

Chandler

Battistutta

. Pregnancy outcomes and health care use: Effects of abuse. Am J Obstet Gynecol 1996; 174: 760–7.

51.

Chambers

Johnson

Dick

Felix

Jones

. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335: 1010–5.

52.

McElhatton

Garbis

Elefant

Vial

Bellemin

Mastroiacovo

. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reprod Toxicol 1996; 10: 285–94.